TAK Operating Cash Flow (Statement)
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) · Operating Cash Flow (Statement)
TAK Operating Cash Flow (Statement)
Latest reported¥953.63B JPYperiod ending
TAK TTM Cash from Operations · JPY (¥413.24B → ¥953.63B)
TTM operating cash flow (statement)
High-resolution chart · PNG
TAK operating cash flow (statement) history
Trailing twelve months (TTM) · JPY. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (JPY) |
|---|---|
| 953,631,000,000 | |
| 1,041,431,000,000 | |
| 1,189,062,000,000 | |
| 1,199,566,000,000 | |
| 1,102,301,000,000 | |
| 1,057,182,000,000 | |
| 1,113,611,000,000 | |
| 876,306,000,000 | |
| 794,248,000,000 | |
| 716,344,000,000 | |
| 731,449,000,000 | |
| 963,227,000,000 | |
| 985,315,000,000 | |
| 977,156,000,000 | |
| 1,059,047,000,000 | |
| 1,028,328,000,000 | |
| 1,040,488,000,000 | |
| 1,123,105,000,000 | |
| 1,148,481,000,000 | |
| 1,018,931,000,000 | |
| 1,031,928,000,000 | |
| 1,010,931,000,000 | |
| 795,408,000,000 | |
| 720,676,000,000 | |
| 694,824,000,000 | |
| 669,752,000,000 | |
| 601,798,000,000 | |
| 551,732,000,000 | |
| 408,797,000,000 | |
| 328,479,000,000 | |
| 336,742,000,000 | |
| 328,658,000,000 | |
| 343,761,000,000 | |
| 377,854,000,000 | |
| 376,566,000,000 | |
| 316,619,000,000 | |
| 285,157,000,000 | |
| 261,363,000,000 | |
| -8,176,000,000 | |
| 42,293,000,000 | |
| 57,618,000,000 | |
| 25,491,000,000 | |
| 203,553,000,000 | |
| 192,836,000,000 | |
| 189,123,000,000 | |
| 182,517,000,000 | |
| 254,983,000,000 | |
| 233,934,000,000 | |
| 249,740,000,000 | |
| 148,335,000,000 | |
| 42,888,000,000 | |
| -946,000,000 | |
| -89,368,000,000 | |
| 118,684,000,000 | |
| 177,886,000,000 | |
| 288,042,000,000 | |
| 326,938,000,000 | |
| 320,646,000,000 | |
| 340,781,000,000 | |
| 343,556,000,000 | |
| 381,168,000,000 | |
| 413,240,000,000 | |
| 386,563,000,000 |